Publications by authors named "Mahboubeh Yazdanifar"

Claim this Profile
M
Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Ru Zhou, Shu-Ta Wu, Mahboubeh Yazdanifar, Chandra Williams, Alexa Sanders

J Immunother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconstructing the cell-cell interaction network among mouse immune cells.
Somayeh Azadian, Alireza Doustmohammadi, Mohadeseh Naseri, Masoud Khodarahmi, Seyed Shahriar Arab, Mahboubeh Yazdanifar

Biotechnol Bioeng· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives.
Pooya Farhangnia, Mahzad Akbarpour, Mahboubeh Yazdanifar, Amir Reza Aref, Ali-Akbar Delbandi

Expert Rev Clin Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantation.
Haideh Namdari, Maryam Hosseini, Mahboubeh Yazdanifar, Hamid Farajifard, Farzad Parvizpour

Rev Med Virol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversial role of γδ T cells in pancreatic cancer.
Fatemeh Nezhad Shamohammadi, Mahboubeh Yazdanifar, Mona Oraei, Mohammad H Kazemi, Azam Roohi

Int Immunopharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hurdles to breakthrough in CAR T cell therapy of solid tumors.
Faroogh Marofi, Harun Achmad, Dmitry Bokov, Walid Kamal Abdelbasset, Zeid Alsadoon, Mahboubeh Yazdanifar

Stem Cell Res Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma.
Mukulika Bose, Priyanka Grover, Alexa J Sanders, Ru Zhou, Mohammad Ahmad, Mahboubeh Yazdanifar

Front Cell Dev Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, Dmitry O Bokov, Walid Kamal Abdelbasset, Mahboubeh Yazdanifar

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.
Priscila Ferreira Slepicka, Mahboubeh Yazdanifar, Alice Bertaina

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technology.
Muhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour-Alitappeh, Arash Sattari, Alexander Seifalian

Biotechnol Bioeng· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Klunko Nataliya Sergeevna, Wanich Suksatan, Mahboubeh Yazdanifar

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-NK cell in cancer immunotherapy; A promising frontier.
Faroogh Marofi, Omar F Abdul-Rasheed, Heshu Sulaiman Rahman, Hendrik Setia Budi, Abduladheem Turki Jalil, Mahboubeh Yazdanifar

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, Wanich Suksatan, Moaed E Al-Gazally, Mahboubeh Yazdanifar

Stem Cell Res Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Ehsan Razeghian, Mahyuddin K M Nasution, Heshu Sulaiman Rahman, Zhanna R Gardanova, Walid Kamal Abdelbasset, Mahboubeh Yazdanifar

Stem Cell Res Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy.
Ali Hassanzadeh, Amjad Hussein Altajer, Heshu Sulaiman Rahman, Marwan Mahmood Saleh, Dmitry O Bokov, Mahboubeh Yazdanifar

Front Cell Dev Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways.
Alireza Shokouhifar, Gholamreza Anani Sarab, Mahboubeh Yazdanifar, Mohammad Fereidouni, Masoumeh Nouri

Cancer Cell Int· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.
Muhammad Sadeqi Nezhad, Meghdad Abdollahpour-Alitappeh, Behzad Rezaei, Mahboubeh Yazdanifar, Alexander Marcus Seifalian

Pharm Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
Faroogh Marofi, Alaa S Al-Awad, Heshu Sulaiman Rahman, Alexander Markov, Walid Kamal Abdelbasset, Mahboubeh Yazdanifar

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M Whilding, Artemis Gavrill

Front Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making a case for using γδ T cells against SARS-CoV-2.
Mahboubeh Yazdanifar, Narges Mashkour, Alice Bertaina

Crit Rev Microbiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M Whilding, Artemis Gavrill

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
Fabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, Alice Bertaina, Irma Airoldi

Cells· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γδ T Cells: The Ideal Tool for Cancer Immunotherapy.
Mahboubeh Yazdanifar, Giulia Barbarito, Alice Bertaina, Irma Airoldi

Cells· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.
Mahboubeh Yazdanifar, Ru Zhou, Priyanka Grover, Chandra Williams, Mukulika Bose

Cells· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
Shu-Ta Wu, Anthony J Fowler, Corey B Garmon, Adam B Fessler, Joshua D Ogle, Mahboubeh Yazdanifar

BMC Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis